APA (7th ed.) Citation

Grigg, S., Khot, A., & Wei, A. H. (2026). Durable response to salvage gilteritinib, allogeneic stem cell rescue and maintenance therapy in relapsed AML with a <italic>FLT3</italic> N676K variant. Leukemia & Lymphoma, 1. https://doi.org/10.1080/10428194.2026.2697465

Chicago Style (17th ed.) Citation

Grigg, Samuel, Amit Khot, and Andrew H. Wei. "Durable Response to Salvage Gilteritinib, Allogeneic Stem Cell Rescue and Maintenance Therapy in Relapsed AML with a FLT3 N676K Variant." Leukemia & Lymphoma 2026: 1. https://doi.org/10.1080/10428194.2026.2697465.

MLA (9th ed.) Citation

Grigg, Samuel, et al. "Durable Response to Salvage Gilteritinib, Allogeneic Stem Cell Rescue and Maintenance Therapy in Relapsed AML with a FLT3 N676K Variant." Leukemia & Lymphoma, 2026, p. 1, https://doi.org/10.1080/10428194.2026.2697465.